Interpace Diagnostics Corp. reported that the company has entered in to an agreement with Best Med Opinion of Tel Aviv, Israel. Best Med has developed a network of specialty providers in the U.S. and other countries to assist local physicians and patients in ensuring all clinical options are known and explored before a particular course of treatment is selected. Best Med has expertise in over 40 specialties, including Ear Nose and Throat, Endocrinology, and Gastroenterology, all focus areas for Interpace's molecular products. As part of the Agreement, Best Medwill provide physicians and patients with information regarding the Company's ThyGenX, ThyraMir, and PancraGen tests, and when these tests are selected to support and inform treatment decisions, manage the logistics associated with collecting and shipping samples to Interpace's CLIA laboratories and report results back to the ordering physician. The Agreement designates Best Med as the exclusive provider of Interpace's products for the country of Israel.